India approves 2 Covid vaccines for emergency use
New Delhi: Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI)...
New Delhi: Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI)...
New Delhi: The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech's 'Covaxin' for emergency use...
New Delhi: In a step closer towards India approving its first coronavirus vaccine, the Subject Expert Committee of the Central Drug...
New Delhi: Serum Institute of India has concluded its presentation before the 10-member Subject Expert Committee of the Drug Regulator for...
New Delhi: The analysis of the additional data and information submitted by Serum Institute of India (SII) and Bharat Biotech is...
New Delhi: Pune-based vaccine-maker Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, on Saturday said...
New Delhi (2 Min Read): Serum Institute of India (SII) has applied for emergency use authorization of the first Made in...
New Delhi: The Serum Institute of India has received approval from the Drugs Controller General of India (DCGI) to resume the...
New Delhi: The Serum Institute of India (SII), which was conducting the India trials for the coronavirus vaccine being developed by...
Mysuru (Karnataka): Clinical trial of the Covishield vaccine, developed by the University of Oxford, began at the JSS Hospital in Mysuru,...